Use of the second-generation antipsychotic, risperidone and secondary weight gain are associated with an altered gut microbiota in children

B C Tyler; C L Oltman; S M Bahr; J R Kirby; T L Burns; L M Teesch; M A Azcarate-Peril; C A Calarge; N Wooldridge; B D Butcher

doi:10.17615/hh2j-cn42

Use of the second-generation antipsychotic, risperidone and secondary weight gain are associated with an altered gut microbiota in children

Identifier:nobleid.org/w1/20260515/CF47C330

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CF47C330.svg?ark=w1%2F20260515%2FCF47C330)](https://nobleid.org/work/w1/20260515/CF47C330)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Use of the second-generation antipsychotic, risperidone and secondary weight gain are associated with an altered gut microbiota in children

Identifier:nobleid.org/w1/20260515/CF47C330

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CF47C330.svg?ark=w1%2F20260515%2FCF47C330)](https://nobleid.org/work/w1/20260515/CF47C330)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work